CG
SWTX

Cutler Group’s SpringWorks Therapeutics SWTX Stock Holding History

Cutler Group’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,000
Closed -$39K – 5505
2022
Q2 		$39K Sell
5,000
-6,100
-55% -$223K ﹤0.01% 2136
2022
Q1 		$4K Buy
+11,100
New +$635K ﹤0.01% 4335

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cutler Group's SWTX Position: Q1 2024 in Review

Cutler Group opened a new position in SpringWorks Therapeutics (SWTX) in Q1 2024: 810 shares worth $39K. The stake represents 0.01% of the portfolio and ranks #776 among its holdings. This is a return to the name: Cutler Group previously reported a position in SWTX as recently as Q2 2022.

Cutler Group first reported a position in SWTX in Q1 2022 and has held it in 3 quarters since. The position peaked at $81K in Q2 2022. 217 funds tracked by Wall St. Rank hold SWTX as of Q1 2024.

  • Cutler Group held 810 shares of SpringWorks Therapeutics worth $39K as of Q1 2024.
  • SpringWorks Therapeutics was a new Cutler Group position in Q1 2024.
  • SpringWorks Therapeutics made up 0.01% of Cutler Group's portfolio in Q1 2024, its #776 holding.
  • Cutler Group first reported a position in SpringWorks Therapeutics in Q1 2022 and has held it in 3 quarters since.
  • Cutler Group's SpringWorks Therapeutics position peaked at $81K in Q2 2022.
  • 217 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.